HLA Class II Alleles DRB1*11:01 and DBQ1*03:01 Unmask Immunogenic Susceptibility to Anti-Nivolumab Antibodies in Combination with Ipilimumab

by Elena Iemma | May 21, 2026

T cell epitope content comparison using EpiCC correlates with vaccine efficacy against heterologous porcine reproductive and respiratory syndrome virus type 2 strains

by Elena Iemma | Jun 25, 2025

T-cell responses to highly conserved SARS-CoV-2 epitopes in Hispanic Americans receiving an mRNA COVID-19 vaccine

by Elena Iemma | May 28, 2025

In silico methods for immunogenicity risk assessment and human homology screening for therapeutic antibodies

by Elena Iemma | Apr 1, 2024

Identification of immunodominant T cell epitopes induced by natural Zika virus infection

by Elena Iemma | Aug 30, 2023